These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 1855750

  • 1. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J, Kreisel W.
    Fortschr Med; 1991 Apr 10; 109(11):245-7. PubMed ID: 1855750
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 6. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
    Schölmerich J, Gerok W.
    Wien Klin Wochenschr; 1986 Nov 21; 98(22):762-9. PubMed ID: 2880425
    [Abstract] [Full Text] [Related]

  • 7. Medical therapy for ulcerative colitis in childhood.
    Ament ME, Vargas JH.
    Semin Pediatr Surg; 1994 Feb 21; 3(1):28-32. PubMed ID: 7914811
    [Abstract] [Full Text] [Related]

  • 8. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL.
    Gastroenterol Clin North Am; 1989 Mar 21; 18(1):35-42. PubMed ID: 2563990
    [Abstract] [Full Text] [Related]

  • 9. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 10. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR.
    CMAJ; 1987 Nov 01; 137(9):799-802. PubMed ID: 2894889
    [Abstract] [Full Text] [Related]

  • 11. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
    Fahrländer H.
    Schweiz Med Wochenschr; 1987 Oct 17; 117(42):1620-3. PubMed ID: 3321418
    [Abstract] [Full Text] [Related]

  • 12. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK, Irvine EJ.
    Am J Gastroenterol; 2000 Jul 17; 95(7):1628-36. PubMed ID: 10925961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease.
    Robinson MG.
    Gastroenterol Clin North Am; 1989 Mar 17; 18(1):43-50. PubMed ID: 2646221
    [Abstract] [Full Text] [Related]

  • 19. Sulfasalazine and 5-ASA compounds.
    Allgayer H.
    Gastroenterol Clin North Am; 1992 Sep 17; 21(3):643-58. PubMed ID: 1355468
    [Abstract] [Full Text] [Related]

  • 20. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA.
    Am J Gastroenterol; 2005 Jun 17; 100(6):1357-61. PubMed ID: 15929770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.